Delivery Order SPE2DB20D1004-SPE2DB25FNKXM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Synthroid 100 microgram tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,478.35, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. The contract involves no set-aside designation and...
- The Defense Logistics Agency awarded a delivery order valued at $1,538.21 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 150 micrograms on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded competitively. The product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, reflecting the company's role as a major...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,786.70 on May 8, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This non-competitive, firm fixed-price delivery order is set to be completed by May 9, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Synthroid 100 micrograms tablets in quantities of 1,000 units, with a ceiling value of $1,061.94. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is due for completion by September 16, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for 1,000 tablets of Synthroid 150 micrograms with a ceiling value of $1,575.33. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is due for ultimate completion on September 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,213.91 to AmerisourceBergen Drug Corp for 1,000 tablets of Synthroid 175 mcg on September 10, 2025, with completion expected by September 11, 2025. This delivery order was competitively awarded with no set-aside designation and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Synthroid is a synthetic thyroid hormone medication commonly...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.09 to AmerisourceBergen Drug Corp for the supply of Synthroid 50 MCG tablets (1,000 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This non-set-aside contract employs firm fixed pricing and is classified as a delivery order under the competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Synthroid 25 microgram tablets (1,000 count) under a firm fixed-price contract valued at $1,430.00. The award, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitively awarded, non-set-aside transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location in the same city. This...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Synthroid 25 microgram tablets in quantities of 1,000 units. This firm fixed price delivery order carries a ceiling value of $8,685.79 and is scheduled for completion by October 27, 2025. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet federal procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order valued at $3,135.68 to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Synthroid 50 microgram tablets in quantities of 1,000 units. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation. This delivery order is issued under...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNKXMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Synthroid 175 mcg tablets (1,000 count) on September 19, 2025, with a ceiling value of $1,893.14 and completion date of September 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is delivering this pharmaceutical product under its broader relationship with DLA. This delivery order represents a small-value transaction within AmerisourceBergen Drug Corp's substantial federal contract portfolio with DLA. The company holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the primary vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The Synthroid delivery exemplifies the company's role as a critical pharmaceutical supplier supporting Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/19/25 |